Pulmonary Adenocarcinoma in Situ

Pulmonary Adenocarcinoma in Situ, also known as bronchioalveolar carcinoma, is related to adenocarcinoma in situ and bronchiolo-alveolar adenocarcinoma. An important gene associated with Pulmonary Adenocarcinoma in Situ is LINC02288 (Long Intergenic Non-Protein Coding RNA 2288), and among its related pathways/superpathways are Infectious disease and TGF-Beta Pathway. The drugs Paclitaxel and Cetuximab have been mentioned in the context of this disorder. Affiliated tissues include lung and lymph node, and related phenotypes are neoplasm and normal